Those determined to outshine the market strategically focus on the selection of individual stocks. Well-chosen stocks have the potential to substantially boost your wealth.
The closing price of Amylyx Pharmaceuticals Inc (NASDAQ: AMLX) was $3.73 for the day, up 6.88% from the previous closing price of $3.49. In other words, the price has increased by $6.88 from its previous closing price. On the day, 0.83 million shares were traded.
Ratios:
Our analysis of AMLX’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 6.67 and its Current Ratio is at 6.67. In the meantime, Its Debt-to-Equity ratio is 0.01 whereas as Long-Term Debt/Eq ratio is at 0.00.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, Robert W. Baird on November 18, 2024, Upgraded its rating to Outperform and sets its target price to $11 from $3 previously.
On October 23, 2024, BofA Securities Upgraded its rating to Buy which previously was Neutral and also upped its target price recommendation from $4.20 to $10.
Mizuho Downgraded its Buy to Neutral on March 18, 2024, whereas the target price for the stock was revised from $32 to $4.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Mar 03 ’25 when Klee Justin B. sold 4,595 shares for $3.15 per share. The transaction valued at 14,483 led to the insider holds 3,196,648 shares of the business.
Cohen Joshua B sold 4,595 shares of AMLX for $14,549 on Mar 03 ’25. The Co-Chief Executive Officer now owns 3,196,652 shares after completing the transaction at $3.17 per share. On Mar 03 ’25, another insider, Mazzariello Gina, who serves as the Chief Legal Officer of the company, sold 1,611 shares for $3.12 each. As a result, the insider received 5,022 and left with 133,310 shares of the company.
Valuation Measures:
For the stock, the TTM Price-to-Sale (P/S) ratio is 3.78 while its Price-to-Book (P/B) ratio in mrq is 1.55.
Stock Price History:
Over the past 52 weeks, AMLX has reached a high of $7.27, while it has fallen to a 52-week low of $1.58. The 50-Day Moving Average of the stock is 5.36%, while the 200-Day Moving Average is calculated to be 14.44%.
Shares Statistics:
A total of 68.63M shares are outstanding, with a floating share count of 64.38M. Insiders hold about 27.34% of the company’s shares, while institutions hold 56.46% stake in the company.
